文章名稱引用次數(shù)

• 2018 ESC/ESH Guidelines for the management of arterial hypertension19
• The 2018 European Heart Rhythm Association Practical Guide on the use of non- vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary13
• Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists12
• How can we reverse bleeding in patients on direct oral anticoagulants?10
• The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure9
• Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study7
• MiR-130a inhibition protects rat cardiac myocytes from hypoxia-triggered apoptosis by targeting Smad46
• Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study6
• Red blood cell distribution width as a prognostic factor of mortality in elderly patients firstly hospitalized due to heart failure6
• 2017 ESC/EACTS Guidelines for the management of valvular heart disease5